Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Change in Inventory (2016 - 2025)

United Therapeutics (UTHR) has disclosed Change in Inventory for 17 consecutive years, with $16.5 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 42.24% to $16.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.6 million through Dec 2025, up 12.15% year-over-year, with the annual reading at $52.6 million for FY2025, 12.15% up from the prior year.
  • Change in Inventory hit $16.5 million in Q4 2025 for United Therapeutics, down from $17.5 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $17.5 million in Q3 2025 to a low of -$5.7 million in Q1 2022.
  • Historically, Change in Inventory has averaged $6.7 million across 5 years, with a median of $7.2 million in 2023.
  • Biggest YoY gain for Change in Inventory was 13800.0% in 2022; the steepest drop was 359.09% in 2022.
  • Year by year, Change in Inventory stood at $100000.0 in 2021, then soared by 13800.0% to $13.9 million in 2022, then tumbled by 49.64% to $7.0 million in 2023, then skyrocketed by 65.71% to $11.6 million in 2024, then soared by 42.24% to $16.5 million in 2025.
  • Business Quant data shows Change in Inventory for UTHR at $16.5 million in Q4 2025, $17.5 million in Q3 2025, and $7.4 million in Q2 2025.